Equities
  • Price (EUR)20.13
  • Today's Change0.816 / 4.22%
  • Shares traded0.00
  • 1 Year change-35.48%
  • Beta--
Data delayed at least 15 minutes, as of Mar 28 2024 18:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

  • Revenue in USD (TTM)142.41bn
  • Net income in USD574.00m
  • Incorporated2014
  • Employees206.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
WBA:NSQ since
announced
Transaction
value
Brookshire Groceries Co-Pharmacy(120)Deal completed10 Jul 202310 Jul 2023Deal completed-25.46%--
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.